Baseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab

Activiteit: Talk or presentation at a conference

Description

Poster Presentation - 21P
Periode14 dec 2018
EvenementstitelESMO Immuno-Oncology Congress 2018
EvenementstypeConference
LocatieGeneva, Switzerland
Mate van erkenningInternational